ReproCELL Incorporated Logo

ReproCELL Incorporated

Provider of stem cell technology and services for research and regenerative medicine.

4978 | T

Overview

Corporate Details

ISIN(s):
JP3974770004
LEI:
Country:
Japan
Address:
横浜市港北区新横浜3−8−11

Description

ReproCELL Incorporated is a global company providing solutions for preclinical and clinical research, with a primary focus on stem cell technology, drug discovery, and regenerative medicine. The company's portfolio includes a wide range of products such as induced pluripotent stem cells (iPSCs), differentiated cells, 3D cell culture models, and specialized reagents like RNA-based reprogramming kits that avoid genomic integration. ReproCELL also offers extensive contract research services, including human tissue assays for evaluating drug efficacy and safety. A key area of expertise is the GMP-compliant manufacturing of clinical-grade iPSCs and iPSC-derived mesenchymal stem cells (iMSCs), supporting the development of advanced cell therapies. The company's tools and services are designed to help academic and commercial scientists accelerate the translation of research into clinical applications.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-11-13 07:35
確認書
Japanese ZIP 8.1 KB
2025-11-13 07:35
半期報告書-第24期(2025/04/01-2026/03/31)
Japanese ZIP 219.0 KB
2025-06-26 02:41
内部統制報告書-第23期(2024/04/01-2025/03/31)
Japanese ZIP 23.4 KB
2025-06-26 02:41
確認書
Japanese ZIP 8.1 KB
2025-06-26 02:40
有価証券報告書-第23期(2024/04/01-2025/03/31)
Japanese ZIP 1.1 MB
2024-11-13 07:31
確認書
Japanese ZIP 8.1 KB
2024-11-13 07:31
半期報告書-第23期(2024/04/01-2025/03/31)
Japanese ZIP 221.1 KB
2024-06-26 03:02
臨時報告書
Japanese ZIP 28.0 KB
2024-06-25 07:31
内部統制報告書-第22期(2023/04/01-2024/03/31)
Japanese ZIP 22.2 KB
2024-06-25 07:30
確認書
Japanese ZIP 8.2 KB
2024-06-25 07:29
有価証券報告書-第22期(2023/04/01-2024/03/31)
Japanese ZIP 1.2 MB
2024-05-23 08:02
臨時報告書
Japanese ZIP 20.0 KB
2024-02-09 07:24
確認書
Japanese ZIP 8.2 KB
2024-02-09 07:23
四半期報告書-第22期第3四半期(2023/10/01-2023/12/31)
Japanese ZIP 227.6 KB
2023-11-10 07:05
四半期報告書-第22期第2四半期(2023/07/01-2023/09/30)
Japanese ZIP 213.2 KB

Automate Your Workflow. Get a real-time feed of all ReproCELL Incorporated filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ReproCELL Incorporated

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ReproCELL Incorporated via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CRONEX.CO.,LTD Logo
A CRO supplying biological species and bio-tissue materials for medical research.
South Korea
215570
C&R Research Inc. Logo
A full-service CRO providing clinical research for pharma and medical device companies.
South Korea
359090
Cte Group Spolka Akcyjna Logo
Diversified firm in HR services, corporate events, and composite materials.
Poland
LPS
curacle co., ltd. Logo
A clinical-stage biopharma developing drugs for intractable vascular diseases.
South Korea
365270
CytoMed Therapeutics Ltd Logo
Clinical-stage developer of off-the-shelf allogeneic cell immunotherapies for cancer.
United States of America
GDTC
Cyxone AB Logo
A clinical-stage biotech developing therapies for autoimmune and autoinflammatory diseases.
Sweden
CYXO
DARWIN AG Logo
Biotechnology firm creating personalized products from individual biological data.
Germany
7V0
DEINOVE Logo
Develops compounds from rare bacteria for cosmetics and new antibiotics.
France
ALDEI
Delta Drone Logo
Develops drone-based systems for the logistics, security, and military sectors.
France
ALDR
Delta-Fly Pharma, Inc. Logo
Biopharmaceutical firm developing novel anticancer drugs from existing components.
Japan
4598

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.